The majority of breast cancer survivors with persistent chemotherapy-induced alopecia will respond to topical minoxidil or low dose oral minoxidil (LDOM), according to dermatologist Professor Rod Sinclair and international colleagues. However prevention of hair loss via scalp hypothermia or novel approaches such as cyclin-dependent kinase 4/6 inhibitors to mitigate taxane-induced hair follicle damage, will be ...
Prevention is better than cure for chemo-induced alopecia: Prof Rod Sinclair
By Mardi Chapman
12 Oct 2021